SPA

Cummins Arabia and Sullivan Palatek Form Strategic Alliance to Distribute Portable Air Compressors in the UAE

Retrieved on: 
Tuesday, December 5, 2023

DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- In a strategic move that promises to reshape the landscape of air compressor market in the UAE, Cummins Arabia has joined forces with Sullivan Palatek Asia (SPA).

Key Points: 
  • DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- In a strategic move that promises to reshape the landscape of air compressor market in the UAE, Cummins Arabia has joined forces with Sullivan Palatek Asia (SPA).
  • This alliance introduces SPA's Diesel Driven Portable Air Compressors to the UAE market, under the exclusive distribution of Cummins Arabia.
  • Sullivan Palatek, with a rich legacy in the compressor industry, mirrors Cummins' ethos of dependability and innovation.
  • With a majority of Sullivan Palatek's range powered by Cummins engines, Cummins Arabia's well-established network and technical capabilities offer unmatched support in the field.

Cummins Arabia and Sullivan Palatek Form Strategic Alliance to Distribute Portable Air Compressors in the UAE

Retrieved on: 
Tuesday, December 5, 2023

DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- In a strategic move that promises to reshape the landscape of air compressor market in the UAE, Cummins Arabia has joined forces with Sullivan Palatek Asia (SPA).

Key Points: 
  • DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- In a strategic move that promises to reshape the landscape of air compressor market in the UAE, Cummins Arabia has joined forces with Sullivan Palatek Asia (SPA).
  • This alliance introduces SPA's Diesel Driven Portable Air Compressors to the UAE market, under the exclusive distribution of Cummins Arabia.
  • Sullivan Palatek, with a rich legacy in the compressor industry, mirrors Cummins' ethos of dependability and innovation.
  • With a majority of Sullivan Palatek's range powered by Cummins engines, Cummins Arabia's well-established network and technical capabilities offer unmatched support in the field.

Creating good, middle-class jobs, and building a strong, secure future with European partners

Retrieved on: 
Friday, November 24, 2023

Canada and the European Union have long shared a commitment to building strong economies that work for the middle class while standing together to address the challenges our world faces.

Key Points: 
  • Canada and the European Union have long shared a commitment to building strong economies that work for the middle class while standing together to address the challenges our world faces.
  • With increased European demand for clean energy, getting even more Canadian resources like critical minerals and hydrogen to European markets will continue to create jobs and growth for Canadians.
  • At the Summit, the Prime Minister highlighted important progress on Canadian hydrogen exports bound for European markets.
  • At the Summit, the Prime Minister welcomed the European Union as the newest partner in the Global Carbon Pricing Challenge .

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

Retrieved on: 
Monday, November 20, 2023

NEW YORK, Nov. 20, 2023 /PRNewswire/ --BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the US Food & Drug Administration (US FDA) has granted the company a meeting to discuss the regulatory path forward for NurOwn® in amyotrophic lateral sclerosis (ALS). The meeting is scheduled to take place on December 6, 2023.  Brainstorm will discuss plans for a Special Protocol Assessment (SPA) with the FDA to agree on the overall protocol design for a confirmatory Phase 3 trial in ALS.

Key Points: 
  • The meeting is scheduled to take place on December 6, 2023.
  • Brainstorm will discuss plans for a Special Protocol Assessment (SPA) with the FDA to agree on the overall protocol design for a confirmatory Phase 3 trial in ALS.
  • "We are pleased that the FDA has granted this expedited in-person meeting to discuss the best path forward for NurOwn for ALS," said Chaim Lebovits, President and Chief Executive Officer of BrainStorm.
  • "Our proposed plan is to conduct a confirmatory Phase 3b trial and it is important that we are aligned with the Agency on the expected requirements for re-submitting a Biologics License Application.

Emeren Group and Eiffel Investment Group's Joint Venture Signs an Agreement to Sell 29 MWp Solar Portfolio in Spain

Retrieved on: 
Tuesday, November 14, 2023

The 29 MWp portfolio comprises three late-stage projects located in the Municipality of Algorfa, Alicante, Spain, in an advanced phase of obtaining the Administrative Authorisation for Construction (the "AAC").

Key Points: 
  • The 29 MWp portfolio comprises three late-stage projects located in the Municipality of Algorfa, Alicante, Spain, in an advanced phase of obtaining the Administrative Authorisation for Construction (the "AAC").
  • Yumin Liu, CEO of Emeren Group, said, "We're delighted to announce the signing of these three utility-scale projects in Spain.
  • Our partnership with Eiffel Investment Group not only strengthens our presence in Spain but also aligns seamlessly with our strategic expansion across Europe.
  • Advisors involved in this transaction include financial advisory from Finergreen, legal counsel provided by Squire Patton Boggs, and technical support from Everoze for Emeren Group and Eiffel Investment Group.

Third time at CIIE, Perfect Diary's parent company marching on the road of science and technology

Retrieved on: 
Thursday, November 9, 2023

SHANGHAI, Nov. 9, 2023 /PRNewswire/ -- This year, Yatsen Group, the parent company of Perfect Diary, joined the Expo with the theme "A Beauty Discovery Journey Powered by Technology" and announced the layout of "Yatsen's Road of Science and Technology" on the spot, aiming to empower the Group's brands including Perfect Diary with its independent innovation and R&D strategy. In addition, Galénic, a high-end skincare brand of Yatsen Group that has been a pioneer in scientific skincare for 45 years, and EVE LOM, luxury healing skincare legend, brought their latest R&D achievements and cutting-edge products to the Expo, and took advantage of the vast stage to show Yatsen Group's continuous commitment to R&D and its roadmap of development both at home and abroad.

Key Points: 
  • One global leading cosmetic factory, Perfect Diary initiated "Integrated Research of Both Makeup and Skincare"
    At this year's Expo, Huang Jinfeng released the strategic layout of "Yatsen's Road of Science and Technology"for the first time.
  • He said: "The national policy promotes independent innovation and quality development of the beauty industry.
  • Yatsen Group has ridden on the tides of policies and trends, and is committed to becoming a beauty enterprise of new technology, boasting brand development driven by science, technology and intellectual creation.
  • On this international stage, Yatsen Group once again presented the new R&D breakthroughs and black technology products from two high-end skincare brands, Galénic and EVE LOM.

Excelerate Energy and Petrobangla Sign Long-Term LNG Sale and Purchase Agreement

Retrieved on: 
Wednesday, November 8, 2023

Excelerate Energy, Inc. (NYSE: EE) (Excelerate or the Company) today announced that it has signed a long-term liquefied natural gas (LNG) sale and purchase agreement (SPA) with the Bangladesh Oil, Gas & Mineral Corporation (Petrobangla).

Key Points: 
  • Excelerate Energy, Inc. (NYSE: EE) (Excelerate or the Company) today announced that it has signed a long-term liquefied natural gas (LNG) sale and purchase agreement (SPA) with the Bangladesh Oil, Gas & Mineral Corporation (Petrobangla).
  • Under the SPA, Petrobangla has agreed to purchase 0.85 to 1.0 million tonnes per annum (MTPA) of LNG from Excelerate for a term of 15 years beginning January 2026.
  • Excelerate will deliver 0.85 MTPA of LNG in 2026 and 2027 and 1 MTPA from 2028 to 2040.
  • “Bangladesh is one of the most dynamic LNG markets in the world, and Excelerate has been a key player since the country began importing LNG.

Gaming Innovation Group secures pole position in casino affiliation by acquiring KaFe Rocks

Retrieved on: 
Wednesday, November 8, 2023

ST JULIANS, Malta, Nov. 7, 2023 /PRNewswire/ -- Gaming Innovation Group Inc. (GiG) has today signed an agreement to acquire affiliate leader KaFe Rocks Ltd.

Key Points: 
  • ST JULIANS, Malta, Nov. 7, 2023 /PRNewswire/ -- Gaming Innovation Group Inc. (GiG) has today signed an agreement to acquire affiliate leader KaFe Rocks Ltd.
  • Through this strategic purchase, GiG Media will cement its position as the dominant lead generator within the lucrative online casino market.
  • Aimee Speight, spokesperson for KaFe Rocks, said: "It's a momentous occasion for KaFe Rocks to join forces with GiG Media.
  • This information is information that Gaming Innovation Group Inc. (GiG) is obliged to make public pursuant to the EU Market Abuse Regulation.

Gaming Innovation Group secures pole position in casino affiliation by acquiring KaFe Rocks

Retrieved on: 
Wednesday, November 8, 2023

ST JULIANS, Malta, Nov. 7, 2023 /PRNewswire/ -- Gaming Innovation Group Inc. (GiG) has today signed an agreement to acquire affiliate leader KaFe Rocks Ltd.

Key Points: 
  • ST JULIANS, Malta, Nov. 7, 2023 /PRNewswire/ -- Gaming Innovation Group Inc. (GiG) has today signed an agreement to acquire affiliate leader KaFe Rocks Ltd.
  • Through this strategic purchase, GiG Media will cement its position as the dominant lead generator within the lucrative online casino market.
  • Aimee Speight, spokesperson for KaFe Rocks, said: "It's a momentous occasion for KaFe Rocks to join forces with GiG Media.
  • This information is information that Gaming Innovation Group Inc. (GiG) is obliged to make public pursuant to the EU Market Abuse Regulation.

Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update

Retrieved on: 
Tuesday, November 7, 2023

BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported financial results for the third quarter ended September 30, 2023, and provided updates on its ophthalmology pipeline.

Key Points: 
  • “We made significant progress at Ocular Therapeutix in the third quarter,” said Antony Mattessich, President and CEO.
  • The Company also recorded gains and losses from debt extinguishment, net, of $14.2 million in the third quarter of 2023.
  • Non-cash charges for stock-based compensation and depreciation and amortization were $5.4 million in the third quarter of 2023 versus $4.7 million for the comparable quarter in 2022.
  • Members of the Ocular Therapeutix management team will host a live conference call and webcast today at 4:30 pm Eastern Time to review the Company's financial results and provide a general business update.